Multimodal treatment of thymic carcinoma: Report of nine cases

Lung Cancer

Volumn 59, Issue 1, 2008, Pages 126-132

  Magois, Eline ^a   Guigay, Joël ^b   Blancard, Patrick Saint ^c   Margery, Jacques ^c   Milleron, Bernard ^d   Lher, Pierre ^c   Jounieaux, Vincent ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c PERCY MILITARY HOSPITAL   (France)

^d HÔPITAL TENON   (France)

Author keywords

Multimodal treatment; Survival; Thymic carcinoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; MESNA; MITOMYCIN; NAVELBINE; PACLITAXEL; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MEGADOSE; EPITHELIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; THYMOMA; THYMUS CANCER; TREATMENT OUTCOME; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; THYMOMA;

EID: 37549046760     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.05.016     Document Type: Article

References (39)

1. Rosai J. Tumors of the thymus. Atlas Tumor Pathol 9 (1976) 34-61
2. Levine G.D., and Rosai. Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 9 5 (1978) 495-515
3. Rosai J., and Barin A. Histopathology typing of tumors of the thymus. World health organization international histological classification of tumors. 2nd ed. (1999), Berling Verlag, New York
4. Marino M., and Muller-Hermelink H.K. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 407 2 (1985) 119-149
5. Suster S., and Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 67 4 (1991) 1025-1032
6. de Montpréville V., and Dulmet E. Thymomes et carcinomes thymiques. Quelles classifications utiliser?. Ann Pathol 16 (1996) 159-166
7. Masaoka A., Yamakawa Y., and Fujii Y. Well-differentiated thymic carcinoma: is it thymic carcinoma or not?. J Thorac Cardiovasc Surg 117 3 (1999) 628-630
8. Ritter J.H., and Wick M.R. Primary carcinomas of the thymus gland. Semin Diagn Pathol 16 1 (1999) 18-31
9. Liu H.C. Primary thymic carcinoma. Ann Thorac Surg. 73 4 (2002) 1076-1081
10. Blumberg D. Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiovasc Surg 115 2 (1998) 303-308 discussion 308-9
11. Chung D.A. Thymic carcinoma-analysis of nineteen clinicopathological studies. Thorac Cardiovasc Surg 48 2 (2000) 114-119
12. Kirchner T., and Mûller-Hermelink H.K. New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol (1989) 167-189 10
13. Masaoka A. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 11 (1981) 2485-2492
14. Hernandez-Ilizaliturri F.J., et al. Multimodality therapy for thymic carcinoma (TCA): results of a 30-year single-institution experience. Am J Clin Oncol 27 1 (2004) 68-72
15. Takeda S. Thymic carcinoma. Clinical institutional experience with 15 patients. Eur J Cardiothorac Surg 26 2 (2004) 401-406
16. Kondo K., and Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76 3 (2003) 878-884 discussion 884-5
17. Lucchi M. Thymic carcinoma: a report of 13 cases. Eur J Surg Oncol 27 7 (2001) 636-640
18. Chalabreysse L. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol 26 12 (2002) 1605-1611
19. Okumura M. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94 3 (2002) 624-632
20. Hsu H.C. Postoperative radiotherapy in thymic carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 52 3 (2002) 801-805
21. Yoh K. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma. Cancer 98 5 (2003) 926-931
22. Chalabreysse L. Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases. Histopathology 44 4 (2004) 367-374
23. Verley J.M., and Hollmann K.H. Thyroma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 55 5 (1985) 1074-1086
24. Lewis J.E. Thymoma. A clinicopathologic review. Cancer 60 11 (1987) 2727-2743
25. Wick M.R. Primary thymic carcinomas. Am J Surg Pathol 6 7 (1982) 613-630
26. Swinborne-Sheldrake K., Gray Jr. G.F., and Glick A.D. Thymic epithelial neoplasms. South Med J 78 7 (1985) 790-800
27. Tseng Y.L. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg 76 4 (2003) 1041-1045
28. Hsu C.P., et al. Thymic carcinoma. Ten years' experience in twenty patients. J Thorac Cardiovasc Surg 107 2 (1994) 615-620
29. Hartmann C.A., et al. Thymic carcinoma. Report of five cases and review of the literature. J Cancer Res Clin Oncol 116 1 (1990) 69-82
30. Lucchi M., et al. The multimodality treatment of thymic carcinoma. Eur J Cardiothorac Surg 19 5 (2001) 566-569
31. Tseng, et al. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg 76 (2003) 1041-1045
32. Venuta F. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76 6 (2003) 1866-1872 discussion 1872
33. Ogawa K., et al. Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases. Cancer 94 12 (2002) 3115-3119
34. Greene M.A., and Malias M.A. Aggressive multimodality treatment of invasive thymic carcinoma. J Thorac Cardiovasc Surg 125 2 (2003) 434-436
35. Loehrer Sr. P. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 91 11 (2001) 2010-2015
36. Liu U.C., et al. Primary thymic carcinoma. Ann Thorac Surg 73 4 (2002) 1076-1081
37. Abiko M. Effect of preoperative concurrent chemo-radiotherapy for thymic carcinoma. Kyobu Geka 55 11 (2002) 965-970
38. Hirabayashi H. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma. Int J Cancer 73 5 (1997) 639-644
39. Strobel P. Thymic carcinoma with overexpression of mutated KIT and the response to Imatinib. N Engl J Med 350 25 (2004) 2625-2626